PlanetConnect has over 25 years of experience in producing custom research events in the Pharma, Telecom, and AgBio sectors. These events bring up to 5000 internal R&D staff to a private 1 - 4 day event, where attendees interact in a secure, proprietary environment at an outside hotel/resort. Companies that outsource events to PlanetConnect in Pharmaceutical/Biotech include BMS, GlaxoSmithKline, J&J, Merck, Biogen, Sanofi, Novartis and Pfizer. These events can encompass Research, Development, PreClinical, Clinical, Manufacturing, Drug Delivery and Diagnostics, IT and Innovation. Upcoming events at: http://events.planetconnect.comIn addition to a full schedule of talks, poster sessions, networking devices and applications, streaming and on-demand video, and attendee networking, PlanetConnect provides well-known, respected outside speakers and up to 250 approved exhibitors. PlanetConnect has over 2,000 active partner/customer companies in it's qualified portfolio with over 1,500 such companies participating in events.PlanetConnect has a unique set of networking tools and devices for large research events, including iPhone/Android platforms and social networking tools.Provide business development and technical project development to a wide range of companies, such as Deutsche Bank (Single Sign On enterprise development and product spinoffs); managed ten contract developers provided to Lucent Technologies for a number of forward looking wireless broadband development projects. Sit on Boards and provide funds for a number of ventures and growing companies.PlanetConnect is a certified Women Owned Business.

The BioPharma Research Council (BRC) is an independent, nonprofit corporation [ 501(c)(6) ] focused on the needs of the biopharmaceutical research community and its product and service suppliers. BRC activities include a number of focused scientific meetings and networking events, including Academic collaboration forums, large IT Symposium (Data 2 Drugs and Diagnostics - D2D), Outsourcing and Licensing focused Symposia, dinner series focused on Therapeutic areas and general research colloquia.

Sold domain name in one of largest domain transactions on record.

Venture funded by Edison Ventures (led by Jim Gunton), led development team in Electronic Software Distribution product ("Web Transporter" and "Infinidisc" technology), leading to company acquisition by larger Columbus company.

See AT&T below. Moved to Lucent at AT&T/Lucent corporate split.

Research and Business Development/Technology Transfer in Optical Fiber Communications, Optical Switching. Standards - IEEE 802, ANSI T1, CCITT/ITU - SONET/SDH, ATM (chair positions on some committees).AT&T Worldnet, High Speed Optical Communications Systems, Business Ventures (AT&T Voice Over IP products, mapping service ("Maps R Us") spin off, signal processing venture) - led or supported strategic partnerships and acquisitions. Worked closely in development and business negotiations of AT&T Worldnet including technical evaluation and business alliances discussions with Worldnet browser choices (Spyglass, Netscape Navigator).

Research in edge emmitting LEDs, lasers, detectors and optical switching, Atmospheric Optical transmission experiments, Optical Transmission System standards (SONET, METROBus). Telecordia (i.e., Bellcore, SAIC) was the central research labs for the regional Bell operating companies after the AT&T divestiture in 1984.

SMG developed a detailed business simulation used within their Wharton undergrad/grad class covering Business development strategy. After class was over, worked part-time with SMG to do port of software to a new platform.